Cipher Pharmaceuticals Inc.
DB:PHE Stock Report
Cipher Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
What is the ownership structure of PHE?| Owner Type | Number of Shares | Ownership Percentage |
|---|
| Institutions | 366,941 | 1.43% |
| Individual Insiders | 11,095,674 | 43.4% |
| General Public | 14,126,565 | 55.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.5%.
Top Shareholders
Top 12 shareholders own 44.79% of the company| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|
| | 9,566,150 | €82.3m | 0% | no data | |
| | 817,149 | €7.0m | 13.6% | no data | |
| | 366,799 | €3.2m | 0.4% | no data | |
| | 251,540 | €2.2m | 0% | no data | |
| Huber Capital Management LLC | 224,700 | €1.9m | 0% | 0.47% | |
| Dimensional Fund Advisors LP | 105,454 | €907.0k | 1.14% | no data | |
| | 84,036 | €722.8k | 0% | no data | |
| Maxam Capital Management Ltd. | 15,000 | €129.0k | 0% | 0.24% | |
| StoneCastle Investment Management Inc. | 12,970 | €111.6k | 0% | 1.46% | |
| Tralucent Asset Management Inc | 8,817 | €75.8k | 0% | 0.19% | |
| | 5,000 | €43.0k | 0% | no data | |
| | 5,000 | €43.0k | 0% | no data | |
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}